Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant KRT6A anticorps

L’anticorps anti-KRT6A Monoclonal Lapin est utilisé pour la détection de KRT6A dans des échantillons de Humain. Il a été validé pour IHC.
N° du produit ABIN7126617
639,45 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Recombinant KRT6A anticorps (ABIN7126617)

Antigène

Voir toutes KRT6A Anticorps
KRT6A (Keratin 6A (KRT6A))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 98
  • 23
  • 13
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 69
  • 41
  • 2
Lapin

Clonalité

  • 59
  • 53
Monoclonal

Conjugué

  • 65
  • 11
  • 7
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp KRT6A est non-conjugé

Application

  • 58
  • 56
  • 36
  • 20
  • 20
  • 9
  • 9
  • 6
  • 6
  • 3
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

KRT6-3997R
  • Fonction

    Recombinant Cytokeratin 6A (KRT6A) (Basal Cell Marker) Antibody

    Specificité

    Cytokeratin 6 is an epidermis-specific type I keratin involved in wound healing. Involved in the activation of follicular keratinocytes after wounding, while it does not play a major role in keratinocyte proliferation or migration. This protein always paired with the type-I keratin K16.Cytokeratin 6 have been identified in epidermis only in samples from plantar glabrous skin while in hairy skin this keratin appeared to be absent in interfollicular epidermis but were clearly present in hair follicle outer root sheath, and this protein also consistently expressed in non-keratinizing stratified squamous epithelia. Among tumors, cytokeratin 6 is typically and strongly expressed in squamous cell carcinomas of different sites, preferentially in inner, maturing layers of the tumor cell nests.Cytokeratin 6 is always used with cytokeratin 5 and is a useful aid for classification of epithelioid mesotheliomas.

    Réactivité croisée (Details)

    Human.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant fragment of human KRT6 (exact sequence is proprietary)

    Isotype

    IgG, kappa
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa cells. Human tonsil or basal cell carcinoma (BCC).

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    KRT6A (Keratin 6A (KRT6A))

    Autre désignation

    KRT6A

    Sujet

    CK6A, CK6B, CK6C, CK6D, CK6E, Keratin Type II Cytoskeletal 6A, Keratin Type II Cytoskeletal 6B, Keratin Type II

    HeLa cells. Human tonsil or basal cell carcinoma (BCC).

    Poids moléculaire

    56kDa

    ID gène

    3853, 700779

    UniProt

    P02538
Vous êtes ici:
Chat with us!